Pacific Biosciences of California Inc logo

PACB

Pacific Biosciences of California Inc

$6.98

Earnings Summary

Revenue
$33.17Mn
Net Profits
$-81.5Mn
Net Profit Margins
-245.68%

Highlights

Revenue:

Pacific Biosciences of California Inc’s revenue jumped 14.4% since last year same period to $33.17Mn in the Q1 2022. On a quarterly growth basis, Pacific Biosciences of California Inc has generated -7.9% fall in its revenue since last 3-months.

Net Profits:

Pacific Biosciences of California Inc’s net profit jumped 6.79% since last year same period to $-81.5Mn in the Q1 2022. On a quarterly growth basis, Pacific Biosciences of California Inc has generated -17.55% fall in its net profits since last 3-months.

Net Profit Margins:

Pacific Biosciences of California Inc’s net profit margin jumped 18.52% since last year same period to -245.68% in the Q1 2022. On a quarterly growth basis, Pacific Biosciences of California Inc has generated -27.64% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Pacific Biosciences of California Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.32
EPS Estimate Current Year
-0.32

Highlights

EPS Estimate Current Quarter:

Pacific Biosciences of California Inc’s earning per share (EPS) estimates for the current quarter stand at -0.32 - a -3.23% fall from last quarter’s estimates.

EPS Estimate Current Year:

Pacific Biosciences of California Inc’s earning per share (EPS) estimates for the current year stand at -0.32.

Key Ratios

Key ratios of the Pacific Biosciences of California Inc post its Q2 2022 earnings

Earning Per Share (EPS)
-0.32

Highlights

Earning Per Share (EPS):

Pacific Biosciences of California Inc’s earning per share (EPS) fell -52.38% since last year same period to -0.32 in the Q2 2022. This indicates that the Pacific Biosciences of California Inc has generated -52.38% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-03
-0.32
-0.32
0%
2022-05-06
-0.31
-0.37
-19.35%

Company Information

Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.

Organisation
Pacific Biosciences of California Inc
Employees
412
Industry
Health Technology